Table S2.
Any ILA or fibrotic ILA distributions across GOLD stages
| Presence and type of ILA | GOLD stages
|
P-value | |||||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | U | ||
| Subjects with no ILA | 787 | 163 | 173 | 58 | 13 | 48 | 0.45 |
| Subjects with any ILA | 75 | 17 | 23 | 6 | 0 | 8 | |
| Subjects with no fibrotic ILA | 852 | 177 | 190 | 60 | 13 | 54 | 0.03 |
| Subjects with any fibrotic ILA | 10 | 3 | 6 | 4 | 0 | 2 | |
Abbreviations: ILA, interstitial lung disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; U, unclassified.